PROSTATILEN ® | VITAPROST ® (Prostate Peptides)
Buy Prostatilen | Vitaprost with the fastest delivery!
Prostatilen | Vitaprost is a medicine of animal origin aimed at treating prostate diseases. It has anti-inflammatory and prostatotropic effects. It helps treat edema, reduce the number of leukocytes in the prostate gland, stabilize the secretion in epithelial cells and stimulate the muscle tone in the bladder. It also improves the blood supply in the prostate gland by reducing blood clotting and prevents the development of thrombosis
The research also shows that Prostatilen | Vitaprost can be used as part of complex therapy for treating male infertility, erectile dysfunction, and acute cystitis.
Both drugs have the same active ingredient, but Prostatilen is used as suppositories or injections, while Vitaprost can be taken orally.
The drug’s main ingredient is bull prostate tissue extract. It is most effective in:
- Reducing the inflammation;
- Improving blood circulation, which helps the prostate gland receive more oxygen;
- Improving sexual performance and semen quality;
- Stimulating the immune system;
- Strengthening the muscles of the bladder and urethra.
Indications
- Chronic abacterial prostatitis;
- Before and after prostate surgery;
- Benign prostatic hyperplasia.
Produced by Cytomed, Russia; Stada / Nizhfarm, Russia.
Check out other products in the Reproductive Health category.
Buy Prostatilen | Vitaprost at our store!
Contents
Lyophilisate for solution for injection in a form of powder
In 1 ampoule:
Active ingredient: the active water-soluble peptide content of the bull prostate tissue extract – 5 mg.
Rectal suppositories
In 1 suppository:
Active ingredient: the active water-soluble peptide content of the bull prostate tissue extract – 30 mg;
Inactive ingredients: dimethyl sulfoxide and polyethylene glycol in the amount essential to make a 2.8 g suppository.
Enteric-coated tablets
In 1 tablet:
Active ingredient: bull prostate tissue extract (powder) 100 mg, with the active peptide content of 20 mg;
Inactive ingredients: sucrose, lactose, calcium stearate, crospovidone, and microcrystalline cellulose.
Dosage and administration
Dosage for the injections is 5–10 mg once a day. Dissolve the lyophilisate in 1-2 ml of 0.9% sodium chloride solution or 0.25–0.5% novocaine solution. The duration of the treatment course is 5–10 days. If necessary, the treatment course can be repeated after 1–6 months.
Suppositories are to be administered rectally. The dosage is 1 suppository 1-2 times a day (in the morning and in the evening). It is recommended to administer a suppository after emptying one’s bowels and having hygiene procedures. Apply a small amount of water to the suppository. Insert the suppository into the rectum. It is recommended to sit or lie with one’s legs closed for 30-40 minutes. The duration of the treatment course is 5–10 days.
Tablets to be administered orally, 1 tablet 2 times a day. Duration of treatment is not less than 30 days in case of benign prostatic hyperplasia or not less than 10 days for chronic abacterial prostatitis.
Contraindications
Hypersensitivity to the components of the drug.
Side effects
Allergic response.
Overdose
No cases of overdose recorded.
Drug interaction
Prostatilen is compatible with antibacterial medications used in treating prostatitis.
Storage conditions
Store at a dark place. Keep out of the reach of children. Storage temperature for is not higher than 20°C for lyophilisate (or tablets), and 8–15°C for suppositories.
Shelf life is 3 years.
Manufacturer
Cytomed, Russia; Stada / Nizhfarm, Russia.
OFFICIAL INSTRUCTION
- Kamalov et al (2006) Use of oral vitaprost in the treatment of chronic abacterial prostatitis https://www.ncbi.nlm.nih.gov/pubmed/17444152
- Mazo et al (2007) Efficacy and safety of a new dosage form of vitaprost (tablets coated with intestinally soluble cover) in patients with prostatic adenoma https://www.ncbi.nlm.nih.gov/pubmed/18649662
- Kamalov et al (2007) Vitaprost forte in the therapy of patients with prostatic adenoma https://www.ncbi.nlm.nih.gov/pubmed/17722619
- V Tkachuk, I Tkachuk (2008) Vitaprost forte efficacy in patients with prostatic adenoma https://www.ncbi.nlm.nih.gov/pubmed/19058362
- Miller et al (2008) Efficacy of vitaprost forte in patients with prostatic adenoma https://www.ncbi.nlm.nih.gov/pubmed/19069497
- Lopatkin et al (2009) Vitaprost plus in the treatment of chronic bacterial prostatitis https://www.ncbi.nlm.nih.gov/pubmed/19670818
- M Sitdykova, A Zubkov (2009) Efficacy of vitaprost forte in the treatment of prostatic adenoma https://www.ncbi.nlm.nih.gov/pubmed/20169719
- Iakovets et al (2011) Experience in vitaprost treatment of patients with chronic abacterial prostatitis and prostatic adenoma after prostatic arteries embolism https://www.ncbi.nlm.nih.gov/pubmed/22279784
- M Davidov (2011) Treatment of prostatic adenoma with concomitant chronic bacterial prostatitis https://www.ncbi.nlm.nih.gov/pubmed/21500490
- D Shafranov, A Mariupol’skiĭ (2011) Vitaprost-forte in the treatment of patients with prostatic adenoma https://www.ncbi.nlm.nih.gov/pubmed/22448483
- Neĭmark et al (2013) The use of drug vitaprost forte in patients with benign prostate hyperplasia https://www.ncbi.nlm.nih.gov/pubmed/23662497
- D Ergakov, A Martov (2013) Application of rectal suppository vitaprost plus before and after transurethral resection of the prostate https://www.ncbi.nlm.nih.gov/pubmed/23789370
- Demidko et al (2014) The use of vitaprost in the treatment of patients with prostate diseases https://www.ncbi.nlm.nih.gov/pubmed/24772777
- D Ergakov, A Martov (2015) Use of Vitaprost (tablets and rectal suppositories) for patients rehabilitation after invasive diagnostic urological interventions https://www.ncbi.nlm.nih.gov/pubmed/28247675
- I Korneev (2017) Russian experience with Vitaprost Forte suppositories in patients with lower urinary tract symptoms and benign prostatic hyperplasia: comparative analysis of studies https://www.ncbi.nlm.nih.gov/pubmed/28845952
- I Kuzmin (2019) Vitaprost Forte in the treament of patients with benign prostatic hyperplasia: pathogenetic basics and clinical results https://www.ncbi.nlm.nih.gov/pubmed/31535821
Related products
Vuka Vuka® is a dietary supplement, which improves libido and used in treating sexual dysfunction. Vuka Vuka is based on a natural herbal complex from Southern Africa. It acts as a tonic, helps treat psychogenic erectile dysfunction, delays premature ejaculation and exacerbates sexual sensations. Vuka Vuka has also proved effective in preventing chronic abacterial prostatitis.
Yohimbine hydrochloride is an alkaloid and an aphrodisiac. It has a wide spectrum of action: treatment of erectile dysfunctions, fat burning, and a general stimulating effect on the body. It is often taken by athletes as a sports nutrition supplement to normalize the cardiovascular system, reduce body weight and increase endurance. The main active ingredient of Yohimbine hydrochloride is an extract from the bark of the evergreen African tree Corynanthe yohimbe.
Mildronate® (also known as Meldonium) is a synthetic analog of gamma-butyrobetaine (GBB), a substance that exists in every cell of the human body. It is used to treat angina, myocardial failure and reduce alcohol withdrawal symptoms. Off-label use of Meldonuim in otherwise healthy individuals includes increasing exercise tolerance, learning, memory, and sexual function.
Mildronate is a perfect alternative for the discontinued Ladasten (Bromantane)! Fast US domestic shipping is available.
Krasniy Koren is a biologically active supplement that has a beneficial effect on the human body, eliminating many functional disorders in the early stages. The active ingredient of Krasniy Koren is Hedysarum neglectum that grows high in the mountains of Altai. Since ancient times, people have used this root to restore strength and energy and to treat various diseases. In advanced cases, the product is used as a supplement to optimize the healing process.